Sancuso Approval History
- FDA approved: Yes (First approved September 12th, 2008)
- Brand name: Sancuso
- Generic name: granisetron
- Company: ProStrakan Group plc
- Treatment for: Nausea/Vomiting, Chemotherapy Induced
Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.
FDA Approval History for Sancuso
|Sep 15, 2008||FDA Approves Sancuso, the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy|
|Jun 2, 2008||ProStrakan Presents Update on Sancuso US Regulatory Review Status|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.